| Terminated | 1 | 60 | Canada, US | KPT-9274, Niacin ER, Nivolumab, Opdivo® | Karyopharm Therapeutics Inc | Solid Tumors, NHL | 02/21 | 06/21 | | |
TEACH, NCT04281420: A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
|
|
| Terminated | 1 | 20 | RoW | ATG-019, KPT-9274, ATG-019 + Niacin ER | Antengene Therapeutics Limited | Solid Tumor, Non-Hodgkin's Lymphoma | 10/23 | 10/23 | | |
